How does a liposome work?
Liposomes are small vesicles with an aqueous compartment enclosed by one or more lipid bilayers. The water-interacting heads and lipid-interacting tails of phospholipids contribute to this arrangement. Depending on its properties, an active ingredient may be associated with the aqueous region or the lipid bilayer.
The structure is a formulation tool that can change how an ingredient behaves. The outcome depends on lipid composition, active properties, manufacturing conditions and the environment in the finished product.
Source: FDA (2018) — Liposome Drug Products; technical characterisation reference; Romano et al. (2024) — Liposomal vitamin C formulation research
Three questions require different evidence
Separating structure, composition and performance makes a technical dossier easier to assess. A single analytical method cannot answer all three questions.
| Question | Evidence to examine | Development purpose |
|---|---|---|
| What is the carrier structure? | Microscopy, particle size and size distribution | Characterisation of the liposomal system |
| How much active is present? | Identity, assay and batch-specific CoA | Ingredient and serving calculations |
| What was observed in research? | Formulation-specific absorption or clinical study | Relevance of findings to the target product |
Source: FDA (2018) — Liposome Drug Products; technical characterisation reference; NCI — Nanotechnology Characterization Laboratory methods
Keep research linked to the tested formulation
A published 2024 vitamin C trial in 27 participants compared a particular liposomal formulation with an equal active amount of standard vitamin C and placebo. A study of this kind describes the tested formulation under its study conditions. Applying its findings to another supplier’s formulation requires a separate justification.
Review the study identity, ingredient composition, administered active amount and observation period together. The word “liposomal” alone does not define a particular absorption ratio or clinical outcome.
Source: Purpura et al. (2024) — Formulation-specific human vitamin C trial
Information that helps start your project
At Biontera, the first assessment starts with your intended product. Capsules, sachets and liquid formats place different demands on an ingredient, so the material specification is reviewed alongside the manufacturing plan.
- The active ingredient and target amount per serving.
- Finished format, other ingredients and planned processing steps.
- Intended shelf life, packaging and storage conditions.
- Required technical documents, sample quantity and estimated annual demand.